• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质瘤中的促血管生成和抗血管生成因子:对新的治疗可能性的影响。

Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities.

机构信息

Department of Biochemical Diagnostics, University Hospital in Białystok, 15-269 Białystok, Poland.

Department of Neurodegeneration Diagnostics, Medical University of Białystok, 15-269 Białystok, Poland.

出版信息

Int J Mol Sci. 2021 Jun 7;22(11):6126. doi: 10.3390/ijms22116126.

DOI:10.3390/ijms22116126
PMID:34200145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8201226/
Abstract

Angiogenesis, a complex, multistep process of forming new blood vessels, plays crucial role in normal development, embryogenesis, and wound healing. Malignant tumors characterized by increased proliferation also require new vasculature to provide an adequate supply of oxygen and nutrients for developing tumor. Gliomas are among the most frequent primary tumors of the central nervous system (CNS), characterized by increased new vessel formation. The processes of neoangiogenesis, necessary for glioma development, are mediated by numerous growth factors, cytokines, chemokines and other proteins. In contrast to other solid tumors, some biological conditions, such as the blood-brain barrier and the unique interplay between immune microenvironment and tumor, represent significant challenges in glioma therapy. Therefore, the objective of the study was to present the role of various proangiogenic factors in glioma angiogenesis as well as the differences between normal and tumoral angiogenesis. Another goal was to present novel therapeutic options in oncology approaches. We performed a thorough search via the PubMed database. In this paper we describe various proangiogenic factors in glioma vasculature development. The presented paper also reviews various antiangiogenic factors necessary in maintaining equilibrium between pro- and antiangiogenic processes. Furthermore, we present some novel possibilities of antiangiogenic therapy in this type of tumors.

摘要

血管生成,即形成新血管的复杂、多步骤的过程,在正常发育、胚胎发生和伤口愈合中起着关键作用。增殖增加的恶性肿瘤也需要新的血管为不断生长的肿瘤提供充足的氧气和营养供应。神经胶质瘤是中枢神经系统(CNS)最常见的原发性肿瘤之一,其特征是新血管形成增加。神经胶质瘤发育所必需的新血管生成过程由许多生长因子、细胞因子、趋化因子和其他蛋白质介导。与其他实体瘤不同,一些生物学条件,如血脑屏障和免疫微环境与肿瘤之间的独特相互作用,代表着神经胶质瘤治疗的重大挑战。因此,本研究的目的是阐述各种促血管生成因子在神经胶质瘤血管生成中的作用,以及正常血管生成和肿瘤血管生成之间的差异。另一个目标是提出肿瘤学治疗方法中的新治疗选择。我们通过 PubMed 数据库进行了全面搜索。本文描述了神经胶质瘤血管生成发育中的各种促血管生成因子。本文还回顾了维持促血管生成和抗血管生成过程平衡所必需的各种抗血管生成因子。此外,我们还提出了这种类型肿瘤的抗血管生成治疗的一些新可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e0e/8201226/3b1798b60260/ijms-22-06126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e0e/8201226/3b1798b60260/ijms-22-06126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e0e/8201226/3b1798b60260/ijms-22-06126-g001.jpg

相似文献

1
Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities.胶质瘤中的促血管生成和抗血管生成因子:对新的治疗可能性的影响。
Int J Mol Sci. 2021 Jun 7;22(11):6126. doi: 10.3390/ijms22116126.
2
Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.联合抗血管生成和肿瘤细胞细胞毒性作用的抗癌疗法可降低胶质瘤异种移植瘤中肿瘤干细胞样细胞的比例。
Cancer Res. 2007 Apr 15;67(8):3560-4. doi: 10.1158/0008-5472.CAN-06-4238.
3
Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.肿瘤血管生成:其机制及在恶性胶质瘤中的治疗意义
J Clin Neurosci. 2009 Sep;16(9):1119-30. doi: 10.1016/j.jocn.2009.02.009. Epub 2009 Jun 24.
4
Mechanisms of glioma-associated neovascularization.胶质瘤相关血管新生的机制。
Am J Pathol. 2012 Oct;181(4):1126-41. doi: 10.1016/j.ajpath.2012.06.030. Epub 2012 Aug 2.
5
Antiangiogenic therapy in malignant glioma: promise and challenge.恶性胶质瘤的抗血管生成治疗:前景与挑战。
Curr Pharm Des. 2007;13(35):3545-58. doi: 10.2174/138161207782794130.
6
Angiogenesis and antiangiogenic therapy for malignant gliomas.恶性胶质瘤的血管生成与抗血管生成治疗
Brain Tumor Pathol. 2004;21(2):69-73. doi: 10.1007/BF02484513.
7
Novel anti-angiogenic therapies for malignant gliomas.恶性胶质瘤的新型抗血管生成疗法。
Lancet Neurol. 2008 Dec;7(12):1152-60. doi: 10.1016/S1474-4422(08)70260-6.
8
NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.过表达 NDRG1 的神经胶质瘤的特点是肿瘤血管生成减少和对抗血管生成治疗的抗性。
Cancer Lett. 2016 Oct 1;380(2):568-576. doi: 10.1016/j.canlet.2015.06.026. Epub 2015 Aug 20.
9
Re: angiogenesis and antiangiogenic therapy for malignant gliomas.关于:恶性胶质瘤的血管生成与抗血管生成治疗
Brain Tumor Pathol. 2005;22(1):51. doi: 10.1007/s10014-004-0172-z.
10
Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy.恶性胶质瘤血管生成的内源性抑制剂:天然抗血管生成疗法。
Neuro Oncol. 2005 Apr;7(2):106-21. doi: 10.1215/S115285170400119X.

引用本文的文献

1
Recent Advances in the Delivery of Bone Morphogenetic Proteins for Targeting Glioma: An Updated Review.用于靶向胶质瘤的骨形态发生蛋白递送的最新进展:综述更新
Int J Nanomedicine. 2025 May 31;20:7093-7112. doi: 10.2147/IJN.S518340. eCollection 2025.
2
Treatment mechanism and research progress of bevacizumab for glioblastoma.贝伐单抗治疗胶质母细胞瘤的作用机制及研究进展
Am J Cancer Res. 2025 Apr 25;15(4):1874-1901. doi: 10.62347/RNUE7193. eCollection 2025.
3
Molecular mechanisms and clinical significance of perineural invasion in malignancies: the pivotal role of tumor-associated Schwann cells in cancer progression and metastasis.

本文引用的文献

1
The GAUGAA Motif Is Responsible for the Binding between circSMARCA5 and SRSF1 and Related Downstream Effects on Glioblastoma Multiforme Cell Migration and Angiogenic Potential.GAUGAA 基序负责 circSMARCA5 与 SRSF1 之间的结合,并对多形性胶质母细胞瘤细胞迁移和血管生成潜能产生相关的下游影响。
Int J Mol Sci. 2021 Feb 7;22(4):1678. doi: 10.3390/ijms22041678.
2
Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy.调节趋化因子/趋化因子受体轴作为一种新型的神经胶质瘤治疗方法。
Pharmacol Ther. 2021 Jun;222:107790. doi: 10.1016/j.pharmthera.2020.107790. Epub 2020 Dec 11.
3
SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway.
恶性肿瘤中神经周围浸润的分子机制及临床意义:肿瘤相关雪旺细胞在癌症进展和转移中的关键作用。
Med Oncol. 2025 Apr 22;42(5):171. doi: 10.1007/s12032-025-02729-x.
4
Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood-Brain Barrier Disruption.突破神经肿瘤学的障碍:血脑屏障破坏的侵入性和非侵入性技术的范围文献综述
Cancers (Basel). 2024 Jan 4;16(1):236. doi: 10.3390/cancers16010236.
5
The role of angiogenic growth factors in the immune microenvironment of glioma.血管生成生长因子在胶质瘤免疫微环境中的作用。
Front Oncol. 2023 Sep 13;13:1254694. doi: 10.3389/fonc.2023.1254694. eCollection 2023.
6
Downregulation of VEGFR2 signaling by cedrol abrogates VEGF‑driven angiogenesis and proliferation of glioblastoma cells through AKT/P70S6K and MAPK/ERK1/2 pathways.雪松醇对VEGFR2信号的下调通过AKT/P70S6K和MAPK/ERK1/2途径消除了VEGF驱动的胶质母细胞瘤细胞的血管生成和增殖。
Oncol Lett. 2023 Jun 22;26(2):342. doi: 10.3892/ol.2023.13928. eCollection 2023 Aug.
7
Plasma metabolomics analyses highlight the multifaceted effects of noise exposure and the diagnostic power of dysregulated metabolites for noise-induced hearing loss in steel workers.血浆代谢组学分析突出了噪声暴露的多方面影响以及代谢物失调对钢铁工人噪声性听力损失的诊断价值。
Front Mol Biosci. 2022 Aug 19;9:907832. doi: 10.3389/fmolb.2022.907832. eCollection 2022.
8
Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma.趋化因子的系统分析表明CCL18是胶质母细胞瘤的一种预后生物标志物。
J Inflamm Res. 2022 Apr 28;15:2731-2743. doi: 10.2147/JIR.S357787. eCollection 2022.
9
Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date.用于神经疾病的脂质基纳米载体:最新技术水平及迄今治疗成功情况综述
Pharmaceutics. 2022 Apr 11;14(4):836. doi: 10.3390/pharmaceutics14040836.
10
The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients.趋化因子CXCL7与血管生成相关,且与结直肠癌患者的不良预后有关。
Front Oncol. 2021 Oct 8;11:754221. doi: 10.3389/fonc.2021.754221. eCollection 2021.
SRSF10 通过抑制 circ-ATXN1 的生成来调节 miR-526b-3p/MMP2 通路进而调控胶质瘤血管生成。
J Exp Clin Cancer Res. 2020 Jun 29;39(1):121. doi: 10.1186/s13046-020-01625-8.
4
Management of glioblastoma: State of the art and future directions.脑胶质瘤的治疗:现状与未来方向。
CA Cancer J Clin. 2020 Jul;70(4):299-312. doi: 10.3322/caac.21613. Epub 2020 Jun 1.
5
The Role of Selected Chemokines and Their Receptors in the Development of Gliomas.选定趋化因子及其受体在神经胶质瘤发展中的作用。
Int J Mol Sci. 2020 May 24;21(10):3704. doi: 10.3390/ijms21103704.
6
LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424.长链非编码 RNA CCAT2 通过海绵吸附 miR-424 激活 VEGFA 信号促进胶质瘤血管生成。
Mol Cell Biochem. 2020 May;468(1-2):69-82. doi: 10.1007/s11010-020-03712-y. Epub 2020 Apr 1.
7
Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.成人大脑肿瘤中的肿瘤发展与血管生成:胶质母细胞瘤
Mol Neurobiol. 2020 May;57(5):2461-2478. doi: 10.1007/s12035-020-01892-8. Epub 2020 Mar 9.
8
The CXCR2/CXCL2 signalling pathway - An alternative therapeutic approach in high-grade glioma.CXCR2/CXCL2 信号通路——高级别神经胶质瘤的一种替代治疗方法。
Eur J Cancer. 2020 Feb;126:106-115. doi: 10.1016/j.ejca.2019.12.005. Epub 2020 Jan 9.
9
Role of Matrix Metalloproteinases in Angiogenesis and Cancer.基质金属蛋白酶在血管生成和癌症中的作用。
Front Oncol. 2019 Dec 6;9:1370. doi: 10.3389/fonc.2019.01370. eCollection 2019.
10
LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis.长链非编码 RNA H19 通过 miR-138/HIF-1α/VEGF 轴促进胶质瘤血管生成。
Neoplasma. 2020 Jan;67(1):111-118. doi: 10.4149/neo_2019_190121N61. Epub 2019 Nov 26.